Mood and performance effects of caffeine in relation to acute and chronic caffeine deprivation. 1995

N J Richardson, and P J Rogers, and N A Elliman, and R J O'Dell
Consumer Sciences Department, Institute of Food Research, Reading, United Kingdom.

The mood and performance effects of caffeine deprivation (either 90 min, overnight, or at least 7 days) and ingestion (70 and 250 mg) were compared in young adults who were normally either moderate consumers (n = 49) or nonconsumers of caffeine (n = 18). Overnight caffeine deprivation produced dysphoric symptoms characteristic of caffeine withdrawal that were reduced, but still present, after longer-term abstinence. Acute caffeine intake affected the withdrawn consumers, nonwithdrawn consumers, and nonconsumers similarly. It increased jitteriness and decrease tiredness and headache. Furthermore, hand steadiness decreased as caffeine dose increased, whereas 70 mg, but not 250 mg, of caffeine was found to enhance performance on a simple reaction time task. These findings support the view that the negative effects experienced after overnight and longer-term caffeine deprivation play a significant role in influencing consumption of caffeine-containing drinks. Therefore, it would appear that to avoid the dysphoric symptoms resulting from both under- and overconsumption, regular caffeine consumers would have to regulate their caffeine intake fairly precisely.

UI MeSH Term Description Entries
D008297 Male Males
D011594 Psychometrics Assessment of psychological variables by the application of mathematical procedures. Psychometric
D011597 Psychomotor Performance The coordination of a sensory or ideational (cognitive) process and a motor activity. Perceptual Motor Performance,Sensory Motor Performance,Visual Motor Coordination,Coordination, Visual Motor,Coordinations, Visual Motor,Motor Coordination, Visual,Motor Coordinations, Visual,Motor Performance, Perceptual,Motor Performance, Sensory,Motor Performances, Perceptual,Motor Performances, Sensory,Perceptual Motor Performances,Performance, Perceptual Motor,Performance, Psychomotor,Performance, Sensory Motor,Performances, Perceptual Motor,Performances, Psychomotor,Performances, Sensory Motor,Psychomotor Performances,Sensory Motor Performances,Visual Motor Coordinations
D011930 Reaction Time The time from the onset of a stimulus until a response is observed. Response Latency,Response Speed,Response Time,Latency, Response,Reaction Times,Response Latencies,Response Times,Speed, Response,Speeds, Response
D002110 Caffeine A methylxanthine naturally occurring in some beverages and also used as a pharmacological agent. Caffeine's most notable pharmacological effect is as a central nervous system stimulant, increasing alertness and producing agitation. It also relaxes SMOOTH MUSCLE, stimulates CARDIAC MUSCLE, stimulates DIURESIS, and appears to be useful in the treatment of some types of headache. Several cellular actions of caffeine have been observed, but it is not entirely clear how each contributes to its pharmacological profile. Among the most important are inhibition of cyclic nucleotide PHOSPHODIESTERASES, antagonism of ADENOSINE RECEPTORS, and modulation of intracellular calcium handling. 1,3,7-Trimethylxanthine,Caffedrine,Coffeinum N,Coffeinum Purrum,Dexitac,Durvitan,No Doz,Percoffedrinol N,Percutaféine,Quick-Pep,Vivarin,Quick Pep,QuickPep
D002908 Chronic Disease Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2). Chronic Condition,Chronic Illness,Chronically Ill,Chronic Conditions,Chronic Diseases,Chronic Illnesses,Condition, Chronic,Disease, Chronic,Illness, Chronic
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D005260 Female Females
D006261 Headache The symptom of PAIN in the cranial region. It may be an isolated benign occurrence or manifestation of a wide variety of HEADACHE DISORDERS. Cephalgia,Hemicrania,Bilateral Headache,Cephalalgia,Cephalodynia,Cranial Pain,Generalized Headache,Head Pain,Ocular Headache,Orthostatic Headache,Periorbital Headache,Retro-Ocular Headache,Sharp Headache,Throbbing Headache,Unilateral Headache,Vertex Headache,Bilateral Headaches,Cephalalgias,Cephalgias,Cephalodynias,Cranial Pains,Generalized Headaches,Head Pains,Headache, Bilateral,Headache, Generalized,Headache, Ocular,Headache, Orthostatic,Headache, Periorbital,Headache, Retro-Ocular,Headache, Sharp,Headache, Throbbing,Headache, Unilateral,Headache, Vertex,Headaches,Headaches, Bilateral,Headaches, Generalized,Headaches, Ocular,Headaches, Orthostatic,Headaches, Periorbital,Headaches, Retro-Ocular,Headaches, Sharp,Headaches, Throbbing,Headaches, Unilateral,Headaches, Vertex,Ocular Headaches,Orthostatic Headaches,Pain, Cranial,Pain, Head,Pains, Cranial,Pains, Head,Periorbital Headaches,Retro Ocular Headache,Retro-Ocular Headaches,Sharp Headaches,Throbbing Headaches,Unilateral Headaches,Vertex Headaches
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

N J Richardson, and P J Rogers, and N A Elliman, and R J O'Dell
August 1998, Physiology & behavior,
N J Richardson, and P J Rogers, and N A Elliman, and R J O'Dell
January 1998, Neuropsychobiology,
N J Richardson, and P J Rogers, and N A Elliman, and R J O'Dell
April 1994, Behavioural pharmacology,
N J Richardson, and P J Rogers, and N A Elliman, and R J O'Dell
January 2018, Sleep science (Sao Paulo, Brazil),
N J Richardson, and P J Rogers, and N A Elliman, and R J O'Dell
January 1993, Psychopharmacology,
N J Richardson, and P J Rogers, and N A Elliman, and R J O'Dell
October 1987, Journal of clinical psychopharmacology,
N J Richardson, and P J Rogers, and N A Elliman, and R J O'Dell
November 2002, Psychopharmacology,
N J Richardson, and P J Rogers, and N A Elliman, and R J O'Dell
May 1985, Psychophysiology,
N J Richardson, and P J Rogers, and N A Elliman, and R J O'Dell
June 2005, Psychopharmacology,
Copied contents to your clipboard!